{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T10:52:03Z","timestamp":1771671123195,"version":"3.50.1"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T00:00:00Z","timestamp":1530835200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2017M621161"],"award-info":[{"award-number":["2017M621161"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2018T110462"],"award-info":[{"award-number":["2018T110462"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Doctoral Starting up Foundation of Liaoning Science and Technology Department","award":["201601139"],"award-info":[{"award-number":["201601139"]}]},{"name":"Foundation of Liaoning Education Committee","award":["201610163L26"],"award-info":[{"award-number":["201610163L26"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81573580"],"award-info":[{"award-number":["81573580"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81503229"],"award-info":[{"award-number":["81503229"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Laboratory of Polysaccharide Bioactivity Evaluation of TCM of Liaoning Province"},{"name":"Key Laboratory of Quality Control of TCM of Liaoning Province","award":["17-137-1-00"],"award-info":[{"award-number":["17-137-1-00"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s12272-018-1047-x","type":"journal-article","created":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T22:29:16Z","timestamp":1530829756000},"page":"785-796","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Role of silibinin in the management of diabetes mellitus and its complications"],"prefix":"10.1007","volume":"41","author":[{"given":"Chun","family":"Chu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dahong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shicheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Ikejima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongkai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanxing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,6]]},"reference":[{"key":"1047_CR1","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/2537216","author":"A Alhusban","year":"2017","unstructured":"Alhusban A, Alkhazaleh E, El-Elimat T (2017) Silymarin ameliorates diabetes-induced proangiogenic response in brain endothelial cells through a GSK-3beta inhibition-induced reduction of VEGF release. J Diabetes Res. \n                    https:\/\/doi.org\/10.1155\/2017\/2537216","journal-title":"J Diabetes Res"},{"key":"1047_CR2","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.2337\/dc11-S062","volume":"34","author":"American Diabetes Association","year":"2011","unstructured":"American Diabetes Association (2011) Diagnosis and classification of diabetes mellitus. Diabetes Care 34:S62\u2013S69","journal-title":"Diabetes Care"},{"issue":"2","key":"1047_CR3","first-page":"25","volume":"3","author":"M Amiri","year":"2014","unstructured":"Amiri M, Motamedi P, Vakili L, Dehghani N, Kiani F, Taheri Z, Torkamaneh S, Nasri P, Nasri H (2014) Beyond the liver protective efficacy of silymarin; bright renoprotective effect on diabetic kidney disease. J Nephropharmacol 3(2):25\u201326","journal-title":"J Nephropharmacol"},{"issue":"3","key":"1047_CR4","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.jnutbio.2012.02.009","volume":"24","author":"I Anestopoulos","year":"2013","unstructured":"Anestopoulos I, Kavo A, Tentes I, Kortsaris A, Panayiotidis M, Lazou A, Pappa A (2013) Silibinin protects H9c2 cardiac cells from oxidative stress and inhibits phenylephrine-induced hypertrophy: potential mechanisms. J Nutr Biochem 24(3):586\u2013594","journal-title":"J Nutr Biochem"},{"key":"1047_CR5","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1089\/dna.2014.2352","volume":"33","author":"R Anuradha","year":"2014","unstructured":"Anuradha R, Saraswati M, Kumar KG, Rani SH (2014) Apoptosis of beta cells in diabetes mellitus. DNA Cell Biol 33:743\u2013748","journal-title":"DNA Cell Biol"},{"key":"1047_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1046\/j.1467-789x.2000.00013.x","volume":"1","author":"A Astrup","year":"2000","unstructured":"Astrup A, Finer N (2000) Redefining Type 2 diabetes: diabesity or obesity dependent diabetes mellitus? Obes Rev 1:57\u201359","journal-title":"Obes Rev"},{"issue":"3","key":"1047_CR7","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.cbi.2013.06.010","volume":"206","author":"F Balszuweit","year":"2013","unstructured":"Balszuweit F, John H, Schmidt A, Kehe K, Thiermann H, Steinritz D (2013) Silibinin as a potential therapeutic for sulfur mustard injuries. Chem Biol Interact 206(3):496\u2013504","journal-title":"Chem Biol Interact"},{"key":"1047_CR8","first-page":"309","volume":"6","author":"I Barbagallo","year":"2015","unstructured":"Barbagallo I, Vanella L, Cambria MT, Tibullo D, Godos J, Guarnaccia L, Zappal\u00e0 A, Galvano F, Li Volti G (2015) Silibinin regulates lipid metabolism and differentiation in functional human adipocytes. Front Pharmacol 6:309","journal-title":"Front Pharmacol"},{"issue":"1","key":"1047_CR9","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1152\/physrev.00015.2003","volume":"84","author":"B Cannon","year":"2004","unstructured":"Cannon B, Nedergaard J (2004) Brown adipose tissue: function and physiological significance. Physiol Rev 84(1):277\u2013359","journal-title":"Physiol Rev"},{"key":"1047_CR10","first-page":"378657","volume":"2013","author":"CL Chang","year":"2013","unstructured":"Chang CL, Lin Y, Bartolome AP, Chen YC, Chiu SC, Yang WC (2013) Herbal therapies for type 2 diabetes mellitus: chemistry, biology, and potential application of selected plants and compounds. Evid-Based Compl Alt 2013:378657","journal-title":"Evid-Based Compl Alt"},{"key":"1047_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1423-0127-18-57","volume":"18","author":"K Chen","year":"2011","unstructured":"Chen K, Jin P, He HH, Xie YH, Xie XY, Mo ZH (2011) Overexpression of Insig-1 protects \u03b2 cell against glucolipotoxicity via SREBP-1c. J Biomed Sci 18:57","journal-title":"J Biomed Sci"},{"key":"1047_CR12","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.3892\/ijmm.2014.1883","volume":"34","author":"K Chen","year":"2014","unstructured":"Chen K, Zhao L, He H, Wan X, Wang F, Mo Z (2014) Silibinin protects beta cells from glucotoxicity through regulation of the Insig-1\/SREBP-1c pathway. Int J Mol Med 34:1073\u20131080","journal-title":"Int J Mol Med"},{"key":"1047_CR13","first-page":"165","volume":"40","author":"K Chen","year":"2015","unstructured":"Chen K, Xu J, He H, Zhao L, Xiong J, Mo Z (2015) Protective effect of silibinin on islet beta cells in C57BL\/6\u00a0J mice fed a highfat diet. J Cent South Univ Med Sci 40:165\u2013170","journal-title":"J Cent South Univ Med Sci"},{"key":"1047_CR14","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.bbrc.2012.02.042","volume":"419","author":"B Cheng","year":"2012","unstructured":"Cheng B, Gong H, Li X, Sun Y, Zhang X, Chen H, Liu X, Zheng L, Huang K (2012) Silibinin inhibits the toxic aggregation of human islet amyloid polypeptide. Biochem Bioph Res Commun 419:495\u2013499","journal-title":"Biochem Bioph Res Commun"},{"key":"1047_CR15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.cbi.2011.11.006","volume":"195","author":"CP Colturato","year":"2012","unstructured":"Colturato CP, Constantin RP, Maeda AS Jr, Constantin RP, Yamamoto NS, Bracht A, Ishii-Iwamoto E, Constantin J (2012) Metabolic effects of silibinin in the rat liver. Chem-Biol Interact 195:119\u2013132","journal-title":"Chem-Biol Interact"},{"issue":"7","key":"1047_CR16","doi-asserted-by":"publisher","first-page":"e101818","DOI":"10.1371\/journal.pone.0101818","volume":"9","author":"S Das","year":"2014","unstructured":"Das S, Roy P, Pal R, Auddy RG, Chakraborti AS, Mukherjee A (2014) Engineered silybin nanoparticles educe efficient control in experimental diabetes. PLoS ONE 9(7):e101818","journal-title":"PLoS ONE"},{"key":"1047_CR17","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.lfs.2008.03.007","volume":"82","author":"D Detaille","year":"2008","unstructured":"Detaille D, Sanchez C, Sanz N, Lopez-Novoa JM, Leverve X, Elmir MY (2008) Interrelation between the inhibition of glycolytic flux by silibinin and the lowering of mitochondrial ROS production in perifused rat hepatocytes. Life Sci 82:1070\u20131076","journal-title":"Life Sci"},{"issue":"8","key":"1047_CR18","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1039\/c3fo30317a","volume":"4","author":"A Dey","year":"2013","unstructured":"Dey A, Lakshmanan J (2013) The role of antioxidants and other agents in alleviating hyperglycemia mediated oxidative stress and injury in liver. Food Funct 4(8):1148\u20131184","journal-title":"Food Funct"},{"issue":"3","key":"1047_CR19","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jpain.2011.11.009","volume":"13","author":"Mannelli L Cesare Di","year":"2012","unstructured":"Di Cesare Mannelli L, Zanardelli M, Failli P, Ghelardini C (2012) Oxaliplatin-induced neuropathy: oxidative stress as pathological mechanism. Protective effect of silibinin. J Pain 13(3):276\u2013284","journal-title":"J Pain"},{"key":"1047_CR20","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.freeradbiomed.2013.03.019","volume":"61","author":"Mannelli L Cesare Di","year":"2013","unstructured":"Di Cesare Mannelli L, Zanardelli M, Failli P, Ghelardini C (2013) Oxaliplatin-induced oxidative stress in nervous system-derived cellular models: could it correlate with in vivo neuropathy? Free Radic Biol Med 61:143\u2013150","journal-title":"Free Radic Biol Med"},{"issue":"10","key":"1047_CR21","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/S0891-5849(02)01043-2","volume":"33","author":"J Dietzmann","year":"2002","unstructured":"Dietzmann J, Thiel U, Ansorge S, Neumann KH, T\u00e4ger M (2002) Thiol-inducing and immunoregulatory effects of flavonoids in peripheral blood mononuclear cells from patients with end-stage diabetic nephropathy. Free Radic Biol Med 33(10):1347\u20131354","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"1047_CR22","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.phymed.2014.12.010","volume":"22","author":"S Ebrahimpour Koujan","year":"2015","unstructured":"Ebrahimpour Koujan S, Gargari BP, Mobasseri M, Valizadeh H, Asghari-Jafarabadi M (2015) Effects of Silybum marianum (L.) Gaertn. (silymarin) extract supplementation on antioxidant status and hs-CRP in patients with type 2 diabetes mellitus: a randomized, triple-blind, placebo-controlled clinical trial. Phytomedicine 22(2):290\u2013296","journal-title":"Phytomedicine"},{"issue":"19","key":"1047_CR23","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.2217\/nnm-2016-0204","volume":"11","author":"YM El-Far","year":"2016","unstructured":"El-Far YM, Zakaria MM, Gabr MM, El Gayar AM, El-Sherbiny IM, Eissa LA (2016) A newly developed silymarin nanoformulation as a potential antidiabetic agent in experimental diabetes. Nanomedicine 11(19):2581\u20132602","journal-title":"Nanomedicine"},{"issue":"2","key":"1047_CR24","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.pharmthera.2005.10.008","volume":"111","author":"H Farhangkhoee","year":"2006","unstructured":"Farhangkhoee H, Khan ZA, Kaur H, Xin X, Chen S, Chakrabarti S (2006) Vascular endothelial dysfunction in diabetic cardiomyopathy: pathogenesis and potential treatment targets. Pharmacol Ther 111(2):384\u2013399","journal-title":"Pharmacol Ther"},{"issue":"5","key":"1047_CR25","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/S0016-5085(10)63686-4","volume":"138","author":"A Federico","year":"2010","unstructured":"Federico A, Andreone P, Brisc MC, Chiaramonte M, Floreani A, Freni MA, Grieco A, Lobello S, Milani S, Okolicsanyi L, Portincasa P, Smedile A, Sporea I, Vecchione R, Blanco CDV, Okolicsanyi L (2010) Effect of silybin in patients with chronic hepatitis: preliminary results of a multicentre randomized controlled trial vs placebo. Gastroenterology 138(5):800","journal-title":"Gastroenterology"},{"issue":"6","key":"1047_CR26","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.neuron.2017.02.005","volume":"93","author":"EL Feldman","year":"2017","unstructured":"Feldman EL, Nave KA, Jensen TS, Bennett DLH (2017) New horizons in diabetic neuropathy: mechanisms, bioenergetics, and pain. Neuron 93(6):1296\u20131313","journal-title":"Neuron"},{"key":"1047_CR27","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1172\/JCI16426","volume":"111","author":"SJ Fisher","year":"2003","unstructured":"Fisher SJ, Kahn CR (2003) Insulin signaling is required for insulin\u2019s direct and indirect action on hepatic glucose production. J Clinl Invest 111:463\u2013468","journal-title":"J Clinl Invest"},{"key":"1047_CR28","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.fct.2016.12.016","volume":"100","author":"J Fu","year":"2017","unstructured":"Fu J, Cui Q, Yang B, Hou Y, Wang H, Xu Y, Wang D, Zhang Q, Pi J (2017) The impairment of glucose-stimulated insulin secretion in pancreatic beta-cells caused by prolonged glucotoxicity and lipotoxicity is associated with elevated adaptive antioxidant response. Food Chem Toxicol 100:161\u2013167","journal-title":"Food Chem Toxicol"},{"key":"1047_CR29","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1159\/000110453","volume":"20","author":"B Guigas","year":"2007","unstructured":"Guigas B, Naboulsi R, Villanueva GR, Taleux N, Lopeznovoa JM, Leverve XM, Elmir MY (2007) The flavonoid silibinin decreases glucose-6-phosphate hydrolysis in perifused rat hepatocytes by an inhibitory effect on glucose-6-phosphatase. Cell Physiol Biochem 20:925\u2013934","journal-title":"Cell Physiol Biochem"},{"key":"1047_CR30","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.apsb.2012.06.002","volume":"2","author":"X Guo","year":"2012","unstructured":"Guo X, Li H, Xu H, Woo S, Dong H, Lu F, Lange AJ, Wu C (2012) Glycolysis in the control of blood glucose homeostasis. Acta Pharm Sin B 2:358\u2013367","journal-title":"Acta Pharm Sin B"},{"key":"1047_CR31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/jvim.12002","volume":"27","author":"ES Hackett","year":"2013","unstructured":"Hackett ES, Twedt DC, Gustafson DL (2013) Milk thistle and its derivative compounds: a review of opportunities for treatment of liver disease. J Vet Intern Med 27:10","journal-title":"J Vet Intern Med"},{"issue":"2","key":"1047_CR32","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jdermsci.2016.07.008","volume":"84","author":"SC Hu","year":"2016","unstructured":"Hu SC, Lan CE (2016) High-glucose environment disturbs the physiologic functions of keratinocytes: focusing on diabetic wound healing. J Dermatol Sci 84(2):121\u2013127","journal-title":"J Dermatol Sci"},{"key":"1047_CR33","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1039\/c2np00074a","volume":"29","author":"HY Hung","year":"2012","unstructured":"Hung HY, Qian K, Morris-Natschke SL, Hsu CS, Lee KH (2012) Recent discovery of plant-derived anti-diabetic natural products. Nat Prod Rep 29:580\u2013606","journal-title":"Nat Prod Rep"},{"key":"1047_CR34","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.bbrc.2010.01.016","volume":"392","author":"T Imasawa","year":"2010","unstructured":"Imasawa T, Koike K, Ishii I, Chun J, Yatomi Y (2010) Blockade of sphingosine 1-phosphate receptor 2 signaling attenuates streptozotocin-induced apoptosis of pancreatic beta-cells. Biochem Biophys Res Commun 392:207\u2013211","journal-title":"Biochem Biophys Res Commun"},{"key":"1047_CR35","volume-title":"IDF Diabetes Atlas","author":"International Diabetes Federation","year":"2017","unstructured":"International Diabetes Federation (2017) IDF Diabetes Atlas, 8th edn. IDF, Brussels","edition":"8"},{"key":"1047_CR36","first-page":"837","volume":"20","author":"E Ishii","year":"1986","unstructured":"Ishii E, Bracht A (1986) Glucose release by the liver under conditions of reduced activity of glucose 6-phosphatase. Braz J Med Biol Res 20:837\u2013843","journal-title":"Braz J Med Biol Res"},{"issue":"2","key":"1047_CR37","doi-asserted-by":"publisher","first-page":"118","DOI":"10.4103\/0973-8258.155060","volume":"9","author":"D Jain","year":"2015","unstructured":"Jain D, Somani R (2015) Silibinin, a bioactive flavanone, prevents the progression of early diabetic nephropathy in experimental type-2 diabetic rats. Int J Green Pharm 9(2):118","journal-title":"Int J Green Pharm"},{"issue":"3","key":"1047_CR38","first-page":"136","volume":"5","author":"D Jain","year":"2016","unstructured":"Jain D, Somani R, Gilhotra R (2016) Silibinin ameliorates hyperglycaemia, hyperlipidemia and prevent oxidative stress in streptozotocin induced diabetes in Sprague Dawley rats. Int J Pharm Res Allied Sci 5(3):136\u2013144","journal-title":"Int J Pharm Res Allied Sci"},{"issue":"5","key":"1047_CR39","first-page":"633","volume":"23","author":"SO Ka","year":"2009","unstructured":"Ka SO, Kim KA, Kwon KB, Park JW, Park BH (2009) Silibinin attenuates adipogenesis in 3T3-L1 preadipocytes through a potential upregulation of the insig pathway. Int J Mol Med 23(5):633","journal-title":"Int J Mol Med"},{"issue":"4","key":"1047_CR40","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1177\/2156587217696929","volume":"22","author":"N Khalili","year":"2017","unstructured":"Khalili N, Fereydoonzadeh R, Mohtashami R, Mehrzadi S, Heydari M, Huseini HF (2017) Silymarin, olibanum, and nettle, a mixed herbal formulation in the treatment of type II diabetes: a randomized, double-blind, Placebo-controlled, clinical trial. J Evid Based Complement Altern Med 22(4):603\u2013608","journal-title":"J Evid Based Complement Altern Med"},{"key":"1047_CR41","doi-asserted-by":"publisher","DOI":"10.1515\/jbcpp-2017-0122","author":"N Kheiripour","year":"2018","unstructured":"Kheiripour N, Karimi J, Khodadadi I, Tavilani H, Goodarzi MT, Hashemnia M (2018) Silymarin prevents lipid accumulation in the liver of rats with type 2 diabetes via sirtuin1 and SREBP-1c. J Basic Clin Physiol Pharmacol. \n                    https:\/\/doi.org\/10.1515\/jbcpp-2017-0122","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"1047_CR42","doi-asserted-by":"publisher","first-page":"C879","DOI":"10.1152\/ajpcell.00069.2014","volume":"306","author":"A Klip","year":"2014","unstructured":"Klip A, Sun Y, Chiu TT, Foley KP (2014) Signal transduction meets vesicle traffic: the software and hardware of GLUT4 translocation. Am J Physiol-Cell Physiol 306:C879\u2013C886","journal-title":"Am J Physiol-Cell Physiol"},{"key":"1047_CR43","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3904\/kjim.2013.28.3.339","volume":"28","author":"MJ Kwon","year":"2013","unstructured":"Kwon MJ, Chung HS, Yoon CS, Lee EJ, Kim TK, Lee SH, Ko KS, Rhee BD, Kim MK, Park JH (2013) Low glibenclamide concentrations affect endoplasmic reticulum stress in INS-1 cells under glucotoxic or glucolipotoxic conditions. Korean J Intern Med 28:339\u2013346","journal-title":"Korean J Intern Med"},{"issue":"5","key":"1047_CR44","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/jnr.23544","volume":"93","author":"Y Lee","year":"2015","unstructured":"Lee Y, Park HR, Chun HJ, Lee J (2015) Silibinin prevents dopaminergic neuronal loss in a mouse model of Parkinson\u2019s disease via mitochondrial stabilization. J Neurosci Res 93(5):755\u2013765","journal-title":"J Neurosci Res"},{"key":"1047_CR45","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s00125-007-0886-7","volume":"51","author":"S Lenzen","year":"2008","unstructured":"Lenzen S (2008) The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 51:216\u2013226","journal-title":"Diabetologia"},{"issue":"1","key":"1047_CR46","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1475-2840-10-62","volume":"10","author":"G Li Volti","year":"2011","unstructured":"Li Volti G, Salomone S, Sorrenti V, Mangiameli A, Urso V, Siarkos I, Galvano F, Salamone F (2011) Effect of silibinin on endothelial dysfunction and ADMA levels in obese diabetic mice. Cardiovasc Diabetol 10(1):62","journal-title":"Cardiovasc Diabetol"},{"key":"1047_CR47","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1590\/1414-431X20144238","volume":"48","author":"HB Li","year":"2015","unstructured":"Li HB, Yang YR, Mo ZJ, Ding Y, Jiang WJ (2015) Silibinin improves palmitate-induced insulin resistance in C2C12 myotubes by attenuating IRS-1\/PI3\u00a0K\/Akt pathway inhibition. Braz J Med Biol Res 48:440\u2013446","journal-title":"Braz J Med Biol Res"},{"issue":"5","key":"1047_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-016-9746-1","volume":"10","author":"G Liamis","year":"2016","unstructured":"Liamis G, Filippatos TD, Liontos A, Elisaf MS (2016) Hyponatremia in patients with liver diseases: not just a cirrhosis-induced hemodynamic compromise. Hepatol Int 10(5):1\u201311","journal-title":"Hepatol Int"},{"issue":"4","key":"1047_CR49","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/j.1476-5381.2012.02227.x","volume":"168","author":"CH Lin","year":"2013","unstructured":"Lin CH, Li CH, Liao PL, Tse LS, Huang WK, Cheng HW, Cheng YW (2013) Silibinin inhibits VEGF secretion and age-related macular degeneration in a hypoxia-dependent manner through the PI-3 kinase\/Akt\/mTOR pathway. Br J Pharmacol 168(4):920\u2013931","journal-title":"Br J Pharmacol"},{"issue":"3","key":"1047_CR50","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.neulet.2011.09.041","volume":"504","author":"G Marrazzo","year":"2011","unstructured":"Marrazzo G, Bosco P, La Delia F, Scapagnini G, Di Giacomo C, Malaguarnera M, Galvano F, Nicolosi A, Li Volti G (2011) Neuroprotective effect of silibinin in diabetic mice. Neurosci Lett 504(3):252\u2013256","journal-title":"Neurosci Lett"},{"key":"1047_CR51","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cmet.2005.07.001","volume":"2","author":"KA Moynihan","year":"2005","unstructured":"Moynihan KA, Grimm AA, Plueger MM, Bernal-Mizrachi E, Ford E, Cras-M\u00e9neur C, Permutt MA, Imai SI (2005) Increased dosage of mammalian Sir2 in pancreatic \u03b2 cells enhances glucose-stimulated insulin secretion in mice. Cell Metab 2:105\u2013117","journal-title":"Cell Metab"},{"issue":"3","key":"1047_CR52","doi-asserted-by":"publisher","first-page":"489","DOI":"10.4239\/wjd.v6.i3.489","volume":"6","author":"MM Nentwich","year":"2015","unstructured":"Nentwich MM, Ulbig MW (2015) Diabetic retinopathy-ocular complications of diabetes mellitus. World J Diabetes 6(3):489\u2013499","journal-title":"World J Diabetes"},{"key":"1047_CR53","doi-asserted-by":"publisher","DOI":"10.5772\/65915","author":"S Nunes","year":"2017","unstructured":"Nunes S, Rolo AP, Palmeira CM, Reis F (2017) Diabetic cardiomyopathy: focus on oxidative stress, mitochondrial dysfunction and inflammation. Cardiomyopathies. \n                    https:\/\/doi.org\/10.5772\/65915","journal-title":"Cardiomyopathies"},{"key":"1047_CR54","first-page":"97","volume":"83","author":"OM Palomino","year":"2017","unstructured":"Palomino OM, Gouveia NM, Ramos S, Martin MA, Goya L (2017) Protective effect of silybum marianum and silibinin on endothelial cells submitted to high glucose concentration. Planta Med 83:97\u2013103","journal-title":"Planta Med"},{"key":"1047_CR55","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.bbrc.2010.11.028","volume":"403","author":"JM Park","year":"2010","unstructured":"Park JM, Kim TH, Bae JS, Kim MY, Kim KS, Ahn YH (2010) Role of resveratrol in FOXO1-mediated gluconeogenic gene expression in the liver. Biochem Bioph Res Commun 403:329\u2013334","journal-title":"Biochem Bioph Res Commun"},{"key":"1047_CR56","doi-asserted-by":"publisher","first-page":"21274","DOI":"10.1038\/srep21274","volume":"6","author":"EH Pilkington","year":"2016","unstructured":"Pilkington EH, Gurzov EN, Kakinen A, Litwak SA, Stanley WJ, Davis TP, Ke PC (2016) Pancreatic beta-cell membrane fluidity and toxicity induced by human islet amyloid polypeptide species. Sci Rep 6:21274","journal-title":"Sci Rep"},{"issue":"2","key":"1047_CR57","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1590\/S0004-27302008000200003","volume":"52","author":"P Pirot","year":"2008","unstructured":"Pirot P, Cardozo AK, Eizirik DL (2008) Mediators and mechanisms of pancreatic beta-cell death in type 1 diabetes. Arq Bras Endocrinol Metabol 52(2):156\u2013165","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"1047_CR58","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.biopha.2018.02.075","volume":"101","author":"R Rahimi","year":"2018","unstructured":"Rahimi R, Karimi J, Khodadadi I, Tayebinia H, Kheiripour N, Hashemnia M, Goli F (2018) Silymarin ameliorates expression of urotensin II (U-II) and its receptor (UTR) and attenuates toxic oxidative stress in the heart of rats with type 2 diabetes. Biomed Pharmacother 101:244\u2013250","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"1047_CR59","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.trsl.2011.12.003","volume":"159","author":"F Salamone","year":"2012","unstructured":"Salamone F, Galvano F, Cappello F, Mangiameli A, Barbagallo I, Li Volti G (2012a) Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis. Transl Res 159(6):477\u2013486","journal-title":"Transl Res"},{"issue":"4","key":"1047_CR60","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.dld.2011.11.010","volume":"44","author":"F Salamone","year":"2012","unstructured":"Salamone F, Galvano F, Marino Gammazza A, Paternostro C, Tibullo D, Bucchieri F, Mangiameli A, Parola M, Bugianesi E, Li Volti G (2012b) Silibinin improves hepatic and myocardial injury in mice with nonalcoholic steatohepatitis. Dig Liver Dis 44(4):334\u2013342","journal-title":"Dig Liver Dis"},{"issue":"4","key":"1047_CR61","doi-asserted-by":"publisher","first-page":"298","DOI":"10.4103\/0974-8490.188880","volume":"8","author":"R Samanta","year":"2016","unstructured":"Samanta R, Pattnaik AK, Pradhan KK, Mehta BK, Pattanayak SP, Banerjee S (2016) Wound healing activity of silibinin in mice. Pharmacogn Res 8(4):298\u2013302","journal-title":"Pharmacogn Res"},{"issue":"3","key":"1047_CR62","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1124\/jpet.109.161612","volume":"332","author":"G Serviddio","year":"2013","unstructured":"Serviddio G, Bellanti F, Giudetti AM, Gnoni GV, Petrella A, Tamborra R, Romano AD, Rollo T, Vendemiale G, Altomare E (2013) A silybin-phospholipid complex prevents mitochondrial dysfunction in a rodent model of nonalcoholic steatohepatitis. J Pharmacol Exp Ther 332(3):922\u2013932","journal-title":"J Pharmacol Exp Ther"},{"key":"1047_CR63","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3742\/OPEM.2008.8.2.146","volume":"8","author":"M Sharma","year":"2008","unstructured":"Sharma M, Anwer T, Pillai KK, Haque SE, Najmi AK, Sultana Y (2008) Silymarin, a flavonoid antioxidant, protects streptozotocin-induced lipid peroxidation and \u03b2-Cell damage in rat pancreas. Orient Pharm Exp Med 8:146\u2013153","journal-title":"Orient Pharm Exp Med"},{"key":"1047_CR64","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/j.biocel.2005.03.002","volume":"37","author":"AG Smith","year":"2005","unstructured":"Smith AG, Muscat GEO (2005) Skeletal muscle and nuclear hormone receptors: Implications for cardiovascular and metabolic disease. Int J Biochem Cell B 37:2047\u20132063","journal-title":"Int J Biochem Cell B"},{"key":"1047_CR65","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1471-2121-14-31","volume":"14","author":"BP Somesh","year":"2013","unstructured":"Somesh BP, Verma MK, Sadasivuni MK, Mammenoommen A, Biswas S, Shilpa PC, Reddy AK, Yateesh AN, Pallavi PM, Nethra S, Smitha R, Neelima K, Narayanan U (2013) Jagannath MR (2013) Chronic glucolipotoxic conditions in pancreatic islets impair insulin secretion due to dysregulated calcium dynamics, glucose responsiveness and mitochondrial activity. BMC Cell Biol 14:31","journal-title":"BMC Cell Biol"},{"key":"1047_CR66","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/ptr.5768","volume":"31","author":"AM Stolf","year":"2017","unstructured":"Stolf AM, Cardoso CC, Acco A (2017) Effects of silymarin on diabetes mellitus complications: a review. Phytother Res 31:366\u2013374","journal-title":"Phytother Res"},{"key":"1047_CR67","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.cbi.2014.12.027","volume":"227","author":"HJ Suh","year":"2015","unstructured":"Suh HJ, Cho SY, Kim EY, Choi HS (2015) Blockade of lipid accumulation by silibinin in adipocytes and zebrafish. Chem-Biol Interact 227:53\u201362","journal-title":"Chem-Biol Interact"},{"issue":"8","key":"1047_CR68","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1002\/ptr.4839","volume":"27","author":"MR Tabandeh","year":"2013","unstructured":"Tabandeh MR, Oryan A, Mohhammad-Alipour A, Tabatabaei-Naieni A (2013) Silibinin regulates matrix metalloproteinase 3 (stromelysine1) gene expression, hexoseamines and collagen production during rat skin wound healing. Phytother Res 27(8):1149\u20131153","journal-title":"Phytother Res"},{"key":"1047_CR69","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nrendo.2016.86","volume":"12","author":"AA Tahrani","year":"2016","unstructured":"Tahrani AA, Barnett AH, Bailey CJ (2016) Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus. Nat Rev Endocrinol 12:566\u2013592","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"1047_CR70","first-page":"36","volume":"28","author":"MJ Tuorkey","year":"2015","unstructured":"Tuorkey MJ, El-Desouki NI, Kamel RA (2015) Cytoprotective effect of silymarin against diabetes-induced cardiomyocyte apoptosis in diabetic rats. Biomed Environ Sci 28(1):36\u201343","journal-title":"Biomed Environ Sci"},{"key":"1047_CR71","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/5147468","author":"L Voroneanu","year":"2016","unstructured":"Voroneanu L, Nistor I, Dumea R, Apetrii M, Covic A (2016) Silymarin in type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. J Diabetes Res. \n                    https:\/\/doi.org\/10.1155\/2016\/5147468","journal-title":"J Diabetes Res"},{"key":"1047_CR72","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1080\/10286020.2012.657180","volume":"14","author":"Q Wang","year":"2012","unstructured":"Wang Q, Liu M, Liu WW, Hao WB, Tashiro S, Onodera S, Ikejima T (2012) In vivo recovery effect of silibinin treatment on streptozotocin-induced diabetic mice is associated with the modulations of Sirt-1 expression and autophagy in pancreatic beta-cell. J Asian Nat Prod Res 14:413\u2013423","journal-title":"J Asian Nat Prod Res"},{"issue":"2","key":"1047_CR73","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1007\/s12035-014-9062-5","volume":"53","author":"M Wang","year":"2016","unstructured":"Wang M, Li YJ, Ding Y, Zhang HN, Sun T, Zhang K, Yang L, Guo YY, Liu SB, Zhao MG, Wu YM (2016) Silibinin prevents autophagic cell death upon oxidative stress in cortical neurons and cerebral ischemia-reperfusion injury. Mol Neurobiol 53(2):932\u2013943","journal-title":"Mol Neurobiol"},{"key":"1047_CR74","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.biopha.2017.02.018","volume":"89","author":"T Wang","year":"2017","unstructured":"Wang T, Cai L, Wang Y, Wang Q, Lu D, Chen H, Ying X (2017) The protective effects of silibinin in the treatment of streptozotocin-induced diabetic osteoporosis in rats. Biomed Pharmacother 89:681\u2013688","journal-title":"Biomed Pharmacother"},{"key":"1047_CR75","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.biopha.2018.01.128","volume":"102","author":"J Yang","year":"2018","unstructured":"Yang J, Sun Y, Xu F, Liu W, Hayashi T, Onodera S, Tashiro S-I, Ikejima T (2018) Involvement of estrogen receptors in silibinin protection of pancreatic beta-cells from TNFalpha- or IL-1beta-induced cytotoxicity. Biomed Pharmacother 102:344\u2013353","journal-title":"Biomed Pharmacother"},{"key":"1047_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/1414-431X20122388","volume":"46","author":"J Yao","year":"2013","unstructured":"Yao J, Zhi M, Gao X, Hu P, Li C, Yang X (2013) Effect and the probable mechanisms of silibinin in regulating insulin resistance in the liver of rats with non-alcoholic fatty liver. Braz J Med Biol 46:1\u20138","journal-title":"Braz J Med Biol"},{"issue":"1\u20133","key":"1047_CR77","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ejphar.2013.09.031","volume":"721","author":"X Ying","year":"2013","unstructured":"Ying X, Sun L, Chen X, Xu H, Guo X, Chen H, Hong J, Cheng S, Peng L (2013) Silibinin promotes osteoblast differentiation of human bone marrow stromal cells via bone morphogenetic protein signaling. Eur J Pharmacol 721(1\u20133):225\u2013230","journal-title":"Eur J Pharmacol"},{"key":"1047_CR78","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.ejphar.2015.09.005","volume":"765","author":"X Ying","year":"2015","unstructured":"Ying X, Chen X, Liu H, Nie P, Shui X, Shen Y, Yu K, Cheng S (2015) Silibinin alleviates high glucose-suppressed osteogenic differentiation of human bone marrow stromal cells via antioxidant effect and PI3\u00a0K\/Akt signaling. Eur J Pharmacol 765:394\u2013401","journal-title":"Eur J Pharmacol"},{"key":"1047_CR79","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nchem.2129","volume":"7","author":"LM Young","year":"2015","unstructured":"Young LM, Saunders JC, Mahood RA, Revill CH, Foster RJ, Tu LH, Raleigh DP, Radford SE, Ashcroft AE (2015) Screening and classifying small-molecule inhibitors of amyloid formation using ion mobility spectrometry-mass spectrometry. Nat Chem 7:73\u201381","journal-title":"Nat Chem"},{"key":"1047_CR80","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1002\/jcb.22984","volume":"112","author":"T Zhan","year":"2011","unstructured":"Zhan T, Digel M, K\u00fcch E-M, Stremmel W, F\u00fcllekrug J (2011) Silybin and dehydrosilybin decrease glucose uptake by inhibiting GLUT proteins. J Cell Biochem 112:849\u2013859","journal-title":"J Cell Biochem"},{"key":"1047_CR81","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.intimp.2013.08.019","volume":"17","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Hai J, Cao M, Zhang Y, Pei S, Wang J, Zhang Q (2013) Silibinin ameliorates steatosis and insulin resistance during non-alcoholic fatty liver disease development partly through targeting IRS-1\/PI3\u00a0K\/Akt pathway. Int Immunopharmacol 17:714\u2013720","journal-title":"Int Immunopharmacol"},{"key":"1047_CR82","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.ejphar.2014.07.033","volume":"740","author":"HT Zhang","year":"2014","unstructured":"Zhang HT, Shi K, Baskota A, Zhou FL, Chen YX, Tian HM (2014a) Silybin reduces obliterated retinal capillaries in experimental diabetic retinopathy in rats. Eur J Pharmacol 740:233\u2013239","journal-title":"Eur J Pharmacol"},{"key":"1047_CR83","doi-asserted-by":"publisher","first-page":"5083","DOI":"10.1096\/fj.14-251744","volume":"28","author":"S Zhang","year":"2014","unstructured":"Zhang S, Liu H, Chuang CL, Li X, Au M, Zhang L, Phillips ARJ, Scott DW, Cooper GJ (2014b) The pathogenic mechanism of diabetes varies with the degree of overexpression and oligomerization of human amylin in the pancreatic islet beta cells. Faseb J 28:5083\u20135096","journal-title":"Faseb J"},{"issue":"1","key":"1047_CR84","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jdiacomp.2014.08.008","volume":"29","author":"D Ziegler","year":"2015","unstructured":"Ziegler D, Fonseca V (2015) From guideline to patient: a review of recent recommendations for pharmacotherapy of painful diabetic neuropathy. J Diabetes Complications 29(1):146\u2013156","journal-title":"J Diabetes Complications"}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12272-018-1047-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-018-1047-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-018-1047-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T15:38:35Z","timestamp":1569253115000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12272-018-1047-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,6]]},"references-count":84,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["1047"],"URL":"https:\/\/doi.org\/10.1007\/s12272-018-1047-x","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,6]]},"assertion":[{"value":"10 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have declared no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}